Emergency Filtration Products Reports Results of Nanoparticle Testing for U.S. Military Filter; Positive Results Expected to Lead to Acceleration of Commercialization of Filter Media for U.S. Military Applications.HENDERSON, Nev. -- Emergency Filtration filtration: see sewerage; water supply. Filtration The separation of solid particles from a fluidsolids suspension of which they are a part by passage of most of the fluid through a septum or membrane that retains most of the solids Products, Inc. (EFP EFP Explosively Formed Penetrator EFP Electronic Field Production EFP Explosively Formed Projectile EFP Exempted Fishing Permit EFP Environmental Farm Planning (Canada) EFP Exempted Fishing Permits ) (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : EMFP EMFP Ethnic/Racial Minority Fellowship Programs ) today announced the results of its testing of various nanoparticles in conjunction with its work to develop filter media for the U.S. military. Funded by a Prototype Development/Testing/Evaluation Grant by the Center for Commercialization of Advanced Technology awarded in September 2004, EFP has tested, using licensed technology, various nanoparticles against five different pathogens or contaminants in this latest round of tests: (1) Staphylococcus staphylococcus (stăf'ələkŏk`əs), any of the pathogenic bacteria, parasitic to humans, that belong to the genus Staphylococcus. The spherical bacterial cells (cocci) typically occur in irregular clusters [Gr. aureous, a bacteria most common in infections in hospitals and community infection; (2) K. Pneumonia pneumonia (n  mōn`yə), acute infection of one or both lungs that can be caused by a bacterium, usually Streptococcus pneumoniae , a bacteria most commonly recognized as an infection in the
lungs; (3) Bacillus subtilis Noun 1. Bacillus subtilis - a species of bacillus found in soil and decomposing organic matter; some strains produce antibioticsBacillus globigii, grass bacillus, hay bacillus - a bacteria found in dirt, such as anthrax anthrax (ăn`thrăks), acute infectious disease of animals that can be secondarily transmitted to humans. It is caused by a bacterium (Bacillus anthracis ; (4) Aspergilus Niger spores, fungi Fungi (fŭn`jī), kingdom of heterotrophic single-celled, multinucleated, or multicellular organisms, including yeasts, molds, and mushrooms. The organisms live as parasites, symbionts, or saprobes (see saprophyte). commonly recognized as black spore mold mold, name for certain multicellular organisms of the various classes of the kingdom Fungi, characteristically having bodies composed of a cottony mycelium. The colors of molds are caused by the spores, which are borne on the mycelium. ; (5) Trichophyton mentagrophytes Trichophyton men·tag·ro·phy·tes n. A zoophilic small-spored fungal parasite that causes infection of hair, skin, and nails. , a fungi that acts as a parasite parasite, plant or animal that at some stage of its existence obtains its nourishment from another living organism called the host. Parasites may or may not harm the host, but they never benefit it. . During testing conducted at Nelson Laboratories EFP selected a total of six different nanoparticles in a test known as a Kill Time Study, which measures the percentage reduction in pathogens at various time intervals. During the testing, the nanoparticles were mixed into a solution and introduced into a controlled environment where the pathogens had been cultured. Although all of the nanoparticles showed effectiveness against one or more of the pathogens, one nanoparticle in particular, known as nanoparticle #1, demonstrated highly significant kill rates against all five pathogens. (The specific nanoparticles are not identified for purposes of national security and trade secrets.) Results for nanoparticle #1 are listed in the tables below:
Results S. aureus
----------------------------------------------------------------------
Exposure Interval Average Control Titer Average Recovered
(CFU/mL) (CFU/mL)
----------------------------------------------------------------------
30 Seconds 7.2 x 10(6) less than20
----------------------------------------------------------------------
2 minutes 7.2 x 10(6) less than20
----------------------------------------------------------------------
5 minutes 7.2 x 10(6) less than20
----------------------------------------------------------------------
Percent Log 10
Reduction Reduction
(%)
--------------------------------------------------
greater than99.99972 greater than5.56
--------------------------------------------------
greater than99.99972 greater than5.56
--------------------------------------------------
greater than99.99972 greater than5.56
--------------------------------------------------
Results K. pneumonia
----------------------------------------------------------------------
Exposure Interval Average Control Titer Average Recovered
(CFU/mL) (CFU/mL)
----------------------------------------------------------------------
30 Seconds 1.6 x 10(5) less than2.0 x 10(1)
----------------------------------------------------------------------
2 minutes 1.6 x 10(5) less than2.0 x 10(1)
----------------------------------------------------------------------
10 minutes 1.6 x 10(5) less than2.0 x 10(1)
----------------------------------------------------------------------
Percent Log 10
Reduction Reduction
(%)
--------------------------------------------------
greater than99.988 greater than3.91
--------------------------------------------------
greater than99.988 greater than3.91
--------------------------------------------------
greater than99.988 greater than3.91
--------------------------------------------------
Results B. subtilis
----------------------------------------------------------------------
Exposure Interval Average Control Titer Average Recovered
(CFU/mL) (CFU/mL)
----------------------------------------------------------------------
30 Seconds 1.8 x 10(5) 9.4 x 10(3)
----------------------------------------------------------------------
2 minutes 1.8 x 10(5) less than2.0 x 10(1)
----------------------------------------------------------------------
10 minutes 1.8 x 10(5) less than2.0 x 10(1)
----------------------------------------------------------------------
Percent Log 10
Reduction Reduction
(%)
--------------------------------------------------
94.9 1.29
--------------------------------------------------
greater than99.989 greater than3.96
--------------------------------------------------
greater than99.989 greater than3.96
--------------------------------------------------
Results A. Niger
----------------------------------------------------------------------
Exposure Interval Average Control Titer Average Recovered
(CFU/mL) (CFU/mL)
----------------------------------------------------------------------
30 Seconds 8.7 x 10(5) less than2.0 x 10(1)
----------------------------------------------------------------------
2 minutes 8.7 x 10(5) less than2.0 x 10(1)
----------------------------------------------------------------------
10 minutes 8.7 x 10(5) less than2.0 x 10(1)
----------------------------------------------------------------------
Percent Log 10
Reduction Reduction
(%)
--------------------------------------------------
greater than99.9977 greater than4.64
--------------------------------------------------
greater than99.9977 greater than4.64
--------------------------------------------------
greater than99.9977 greater than4.64
--------------------------------------------------
Results T. mentagrophytes
----------------------------------------------------------------------
Exposure Interval Average Control Titer Average Recovered
(CFU/mL) (CFU/mL)
----------------------------------------------------------------------
30 Seconds 1.5 x 10(6) less than2.0 x 10(1)
----------------------------------------------------------------------
2 minutes 1.5 x 10(6) less than2.0 x 10(1)
----------------------------------------------------------------------
10 minutes 1.5 x 10(6) less than2.0 x 10(1)
----------------------------------------------------------------------
Percent Log 10
Reduction Reduction
(%)
--------------------------------------------------
greater than99.9986 greater than4.86
--------------------------------------------------
greater than99.9986 greater than4.86
--------------------------------------------------
greater than99.9986 greater than4.86
--------------------------------------------------
Note to Editors: In the tables above, all numbers surrounded by
parentheses should be read as superscript.
"The results of the recent testing, especially for nanoparticle #1, are nothing short of spectacular," said Douglas K. Beplate, President, EFP. "The striking biocidal bi·o·cid·al adj. Of or relating to an agent that is destructive to living organisms. biocidal (bī´ōsī´d powers of nanoparticle #1 against five disparate, potentially life-threatening pathogens, coupled with the established efficacy of our 2H Filter technology - which filters out greater than 99.99% at a particle size Particle size, also called grain size, refers to the diameter of individual grains of sediment, or the lithified particles in clastic rocks. The term may also be applied to other granular materials. of 0.027 microns - means that we now have the ability to create a filter media which will not only prevent various infections, but will also exterminate them." Mr. Beplate went on to add, "I am highly confident that these findings will lead to an acceleration of our efforts to develop product applications for the U.S. military; we expect to enter into partnership discussions with a number of Department of Defense-approved filter manufacturers in the near future to develop U.S. military product applications for the company's nano-enhanced filter media. In addition, I believe that these results will expedite ex·pe·dite tr.v. ex·pe·dit·ed, ex·pe·dit·ing, ex·pe·dites 1. To speed up the progress of; accelerate. 2. our ability to incorporate the nano-enhanced filter media in all of our products and greatly enhance their appeal to the marketplace." The U.S. military has previously identified over 1,000 potential applications for EFP's filter media technology. The company intends to work closely with the U.S. military and DOD-approved manufacturers selected by the U.S. military, to develop those applications that the U.S. military deems to have the highest priority in its strategic plans. The company expects to have its filter media in use by the U.S. military in late 2005, pending the successful outcome of final testing. About Emergency Filtration Products Inc. EFP (www.emergencyfiltration.com) is an air filtration products manufacturer whose technology provides filtration efficiencies of "greater than 99.99% at a particle size of 0.027 microns. Its initial products were developed for the medical market: the Vapor Isolation Valve(TM); RespAide -- a CPR mask A CPR mask is a device used to deliver rescue breaths during a cardiac arrest or respiratory arrest safely. The mask has a built in disposable one-way filter valve which lets the air from the rescuer deliver to the patient while any substances from the patient (eg. used for resuscitation resuscitation /re·sus·ci·ta·tion/ (-sus?i-ta´shun) restoration to life of one apparently dead. cardiopulmonary resuscitation of respiratory/cardiac arrest cases; an A.E.D. prep kit; and the 2H Breathing Circuit Filter. Each has received FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval. EFP's 2H NanoMask with 27 nanometers filtration capability relies on the company's core 2H Technology(TM) filtration system, which utilizes a combination of hydrophobic hydrophobic /hy·dro·pho·bic/ (-fo´bik) 1. pertaining to hydrophobia (rabies). 2. not readily absorbing water, or being adversely affected by water. 3. and hydrophilic hydrophilic /hy·dro·phil·ic/ (-fil´ik) readily absorbing moisture; hygroscopic; having strongly polar groups that readily interact with water. hy·dro·phil·ic adj. filters able to capture and isolate isolate /iso·late/ (i´sah-lat) 1. to separate from others. 2. a group of individuals prevented by geographic, genetic, ecologic, social, or artificial barriers from interbreeding with others of their kind. bacterial and viral microorganisms with efficiencies of 99.99%. The environmental mask utilizes the company's patented 2H Technology(TM) and nano-technology to enhance the capture-and-isolation characteristics of the filter media. In addition to filtration products, the company also supplies Superstat, a modified hemostatic hemostatic /he·mo·stat·ic/ (he?mo-stat´ik) 1. causing hemostasis, or an agent that so acts. 2. due to or characterized by stasis of the blood. he·mo·stat·ic adj. collagen collagen (kŏl`əjən), any of a group of proteins found in skin, ligaments, tendons, bone and cartilage, and other connective tissue. Cells called fibroblasts form the various fibers in connective tissue in the body. , to the medical market and U.S. military for extreme wound care. Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement: This release may contain statements that are forward looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. EFP does not undertake to update forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future results of the company could differ significantly from such forward-looking statements. Specifically, the selection of EFP products for testing does not guarantee that such products, even if successful in the tests, will be ordered by any branch of the U.S. military. In addition, even if orders are placed following testing, production of products will take some time and the orders may not involve significant sales to the U.S. military. Sales may be dependent both the perceived need for EFP's products in the U.S. military and in the civilian marketplace as well as the competitive performance of such products in the marketplace. Finally, even if potential additional applications are identified, such applications may involve additional research and development prior to implementation. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion